Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

SEEL

Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is devoted to developing and commercializing novel therapeutics that treat respiratory, central nervous system and other disor...

Seelos Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

CDXC

ChromaDex

ChromaDex Corporation, a leading bioscience company developing products for healthy aging, operates through three segments: Consumer Products, Ingredients, and Analytical Reference Standards and Se...

ChromaDex Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ADMS

Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals Inc. is a leading specialty pharmaceutical company that is primarily focused on developing and commercializing therapeutics that aim to address chronic disorders related to t...

Adamas Pharmaceuticals Inc Annual Report 2019

Healthcare Drugs - Generic NASDAQ 51-200

RDUS

Radius Health

Radius is a biopharmaceutical company that focuses on developing cutting-edge therapeutics in the fields of oncology, endocrine diseases, and osteoporosis. Their research is underpinned by a rigoro...

Radius Health Annual Report 2020

Healthcare NASDAQ 51-200

BEAM

Beam Therapeutics

Cambridge-based Beam Therapeutics Inc. is making waves in the biotechnology industry by developing precision genetic medicines to aid patients fighting serious diseases in the United States. Among ...

Beam Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

MGNX

MacroGenics

Maryland-based biopharmaceutical company MacroGenics, Inc. is making strides in the fight against cancer with its line of antibody-based therapeutics. The company's flagship product, MARGENZA, has ...

MacroGenics Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

GMAB

Genmab

Danish-based Genmab A/S is at the forefront of developing antibody therapeutics for cancer and other diseases. Its product line includes DARZALEX, a human monoclonal antibody for the treatment of m...

Genmab Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

CUV

Clinuvel Pharmaceuticals

Founded in 1987, Clinuvel is headquartered in Melbourne, Australia and has operations in Europe, Asia, and the United States. The company's flagship product, SCENESSE, is a first-of-its-kind photop...

Clinuvel Pharmaceuticals Annual Report 2023

Healthcare Biotechnology ASX 11-50

BBIO

BridgeBio Pharma

BridgeBio Pharma, Inc. is making strides in the realm of genetic disease treatments. The company boasts a vast pipeline of 30 development programs, ranging from early exploration to late-stage deve...

BridgeBio Pharma Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

NBRV

Nabriva Therapeutics plc

Nabriva Therapeutics Plc, a Dublin-based biopharmaceutical company, is making waves in the development and commercialization of groundbreaking anti-infective agents aimed at treating serious infect...

Nabriva Therapeutics plc Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

ANAB

AnaptysBio, Inc.

San Diego-based AnaptysBio, Inc. is a clinical-stage biotechnology firm focused on delivering immunology therapeutics. The company's product portfolio includes Imsidolimab, an antibody that inhibit...

AnaptysBio, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MGLN

Magellan Health Services Inc.

Magellan Health Services is a leading provider of managed behavioral healthcare, radiology benefits management, specialty pharmaceutical management, and Medicaid administration products and service...

Magellan Health Services Inc. Annual Report 2019

Healthcare Health Care Plans NASDAQ 5001-10,000

CDY

Cellmid Limited

Cellmid Limited, an Australian consumer health company, has been making waves in the anti-aging industry around the world. The company develops, manufactures, and markets products related to hair, ...

Cellmid Limited Annual Report 2020

Healthcare Biotechnology ASX 11-50

AKRX

Akorn Inc.

Akorn Inc. is a generic pharmaceutical company that focuses on the development, manufacturing, and marketing of a range of pharmaceutical products. The products are multi-source and branded pharmac...

Akorn Inc. Annual Report 2018

Healthcare Drugs - Generic NASDAQ 1001-5000

RX

Biosyent

BioSyent, a specialty pharmaceutical company listed on the TSX Venture Exchange, is focused on acquiring or in-licensing innovative pharmaceutical products that have been proven to be safe and effe...

Biosyent Annual Report 2023

Healthcare Drugs - Generic TSX-V 11-50